Jonathan B. Mitchem

3.4k total citations · 2 hit papers
46 papers, 2.6k citations indexed

About

Jonathan B. Mitchem is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Jonathan B. Mitchem has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Immunology and 13 papers in Cancer Research. Recurrent topics in Jonathan B. Mitchem's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune cells in cancer (11 papers) and Cancer Genomics and Diagnostics (9 papers). Jonathan B. Mitchem is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune cells in cancer (11 papers) and Cancer Genomics and Diagnostics (9 papers). Jonathan B. Mitchem collaborates with scholars based in United States, Germany and Iraq. Jonathan B. Mitchem's co-authors include David C. Linehan, Brian A. Belt, Andrea Wang‐Gillam, Peter S. Goedegebuure, Dominic E. Sanford, David G. DeNardo, Danielle Carpenter, Roheena Z. Panni, S. Peter Goedegebuure and Matthew R. Porembka and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Jonathan B. Mitchem

42 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

2012 759 citations Jonathan B. Mitchem, Donal J. Brennan et al. Cancer Research profile →
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

2013 479 citations Dominic E. Sanford, Brian A. Belt et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Jonathan B. Mitchem

Since Specialization

Citations

This map shows the geographic impact of Jonathan B. Mitchem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan B. Mitchem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan B. Mitchem more than expected).

Fields of papers citing papers by Jonathan B. Mitchem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan B. Mitchem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan B. Mitchem. The network helps show where Jonathan B. Mitchem may publish in the future.

Co-authorship network of co-authors of Jonathan B. Mitchem

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan B. Mitchem. A scholar is included among the top collaborators of Jonathan B. Mitchem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan B. Mitchem. Jonathan B. Mitchem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative multi-omics evaluation of the tumor microenvironment in dog and human hepatocellular carcinoma 2025 ·(unknown), Jeffrey N. Bryan, Guangfu Li, (unknown), William T. N. Culp, Peter J. Dickinson, (unknown), Kate Megquier, An Hong, (unknown), (unknown), Jonathan B. Mitchem, Wesley C. Warren	0
2	Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids 2024 ·Clinical Cancer Research ·Kanve N. Suvilesh, Yariswamy Manjunath, (unknown), Mohamed Gadelkarim, Murugesan Raju, Akhil Srivastava, Guangfu Li, Wesley C. Warren, Chi‐Ren Shyu, Feng Gao, Matthew A. Ciorba, Jonathan B. Mitchem, Satyanarayana Rachagani, Jussuf T. Kaifi	7
3	Colorectal Cancer-Associated Myofibroblasts Exhibit Enhanced Angiogenin Expression and Signaling via the PLXNB2 Receptor 2024 ·Journal of Surgical Research ·(unknown), (unknown), Jonathan B. Mitchem, James Yoo	2
4	Identifying gene expression programs in single-cell RNA-seq data using linear correlation explanation 2024 ·Journal of Biomedical Informatics ·(unknown), K. S. M. Tozammel Hossain, Jussuf T. Kaifi, Wesley C. Warren, Chi‐Ren Shyu, Jonathan B. Mitchem	0
5	Understanding common key indicators of successful and unsuccessful cancer drug trials using a contrast mining framework on ClinicalTrials.gov 2023 ·Journal of Biomedical Informatics ·(unknown), (unknown), Jonathan B. Mitchem, (unknown), Jussuf T. Kaifi, Chi‐Ren Shyu	4
6	Explainable artificial intelligence in high-throughput drug repositioning for subgroup stratifications with interventionable potential 2021 ·Journal of Biomedical Informatics ·(unknown), (unknown), Jonathan B. Mitchem, Christos Papageorgiou, Jussuf T. Kaifi, Wesley C. Warren, Chi‐Ren Shyu	11
7	Epigenetic Regulation of Cancer Immune Cells 2021 ·Seminars in Cancer Biology ·(unknown), V. Radhakrishnan, Kanve N. Suvilesh, Yariswamy Manjunath, Guangfu Li, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Wesley C. Warren, Jussuf T. Kaifi, Jonathan B. Mitchem	20
8	Immunity, immunotherapy, and rectal cancer: A clinical and translational science review 2020 ·Translational research ·Ebunoluwa Otegbeye, Jonathan B. Mitchem, Haeseong Park, Aadel A. Chaudhuri, Hyun Kim, Matthew G. Mutch, Matthew A. Ciorba	12
9	18F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer 2020 ·Translational Lung Cancer Research ·Diego M. Avella, Yariswamy Manjunath, Amolak Singh, Chelsea B. Deroche, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Jonathan B. Mitchem, Eric O. Kwon, Guangfu Li, Jussuf T. Kaifi	5
10	Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer 2020 ·BMC Cancer ·Yuanyuan Shen, Yue Guan, (unknown), Chi‐Ren Shyu, Jonathan B. Mitchem	11
11	Circulating Giant Tumor-Macrophage Fusion Cells Are Independent Prognosticators in Patients With NSCLC 2020 ·Journal of Thoracic Oncology ·Yariswamy Manjunath, Jonathan B. Mitchem, Kanve N. Suvilesh, Diego M. Avella, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Chelsea B. Deroche, Klaus Pantel, Guangfu Li, Jussuf T. Kaifi	48
12	FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer 2020 ·Frontiers in Oncology ·Yue Guan, (unknown), (unknown), Mark A. Daniëls, Jonathan B. Mitchem, Emma Teixeiro	50
13	Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer 2014 ·Cancer Immunology Immunotherapy ·Roheena Z. Panni, Dominic E. Sanford, Brian A. Belt, Jonathan B. Mitchem, Lori A. Worley, Brian D. Goetz, Pinku Mukherjee, Andrea Wang‐Gillam, Daniel C. Link, David G. DeNardo, S. Peter Goedegebuure, David C. Linehan	173
14	Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis breakdown → 2013 ·Clinical Cancer Research ·Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni, Allese Mayer, Anjali D. Deshpande, Danielle Carpenter, Jonathan B. Mitchem, Stacey M. Plambeck-Suess, Lori A. Worley, Brian D. Goetz, Andrea Wang‐Gillam, Timothy J. Eberlein, David G. DeNardo, S. Peter Goedegebuure, David C. Linehan	479
15	Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses breakdown → 2012 ·Cancer Research ·Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff, Brian A. Belt, Yu Zhu, Dominic E. Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica‐Worms, Stephen M. Hewitt, Girish Mallya Udupi, William M. Gallagher, Craig D. Wegner, Brian L. West, Andrea Wang‐Gillam, Peter S. Goedegebuure, David C. Linehan, David G. DeNardo	759
16	A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma 2012 ·Investigational New Drugs ·Andrea Wang‐Gillam, Stacey M. Plambeck-Suess, Peter S. Goedegebuure, Peter O. Simon, Jonathan B. Mitchem, John R. Hornick, Steven Sorscher, Joel Picus, Rama Suresh, A. Craig Lockhart, Benjamin Tan, (unknown)	81
17	Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer 2011 ·Current Cancer Drug Targets ·Peter S. Goedegebuure, Jonathan B. Mitchem, Matthew R. Porembka, Marcus Tan, Brian A. Belt, Andrea Wang‐Gillam, William E. Gillanders, William G. Hawkins, David C. Linehan	91
18	Long-Term Results of Resection of Adenocarcinoma of the Body and Tail of the Pancreas Using Radical Antegrade Modular Pancreatosplenectomy Procedure 2011 ·Journal of the American College of Surgeons ·Jonathan B. Mitchem, Nicholas Hamilton, Feng Gao, William G. Hawkins, David C. Linehan, Steven M. Strasberg	108
19	A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: Management and outcomes 2011 ·Surgery ·John R. Hornick, Fabian M. Johnston, Peter O. Simon, (unknown), (unknown), Jonathan B. Mitchem, Riad R. Azar, David C. Linehan, Steven M. Strasberg, Steven A. Edmundowicz, William G. Hawkins	32
20	Close Link between CD4⁺and CD8⁺T Cell Proliferation Defects in Patients with Human Immunodeficiency Virus Disease and Relationship to Extended Periods of CD4⁺Lymphopenia 2002 ·The Journal of Infectious Diseases ·Scott F. Sieg, Jonathan B. Mitchem, Douglas A. Bazdar, Michael M. Lederman	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact